News

Sarepta Therapeutics stock sinks further Tuesday after halting shipment of bestselling drug Elevidys
Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...
Sarepta Therapeutics stock sinks further Tuesday, after halting shipment of bestselling drug Elvidys
Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...
Managed Healthcare Executive56m
Sarepta to Pause Shipments of the Gene Therapy Elevidys
Sarepta officials said the temporary halt in shipments was done to maintain a productive working relationship with regulators ...
Sarepta Faces Fresh Setback. Why Now’s Not the Time to Buy the Stock.
Sarepta stock fell after it agreed to voluntarily halt shipments of its experimental medicine Elevidys for Duchenne muscular ...
Wall Street dips in premarket but remains near record highs as another raft of earnings pours in
World shares were mixed on Tuesday after U.S. stock indexes inched to more records at the start of a week of profit updates ...
El Mundo on MSN33m
World markets are mixed and Japan's shares dip after election leaves Ishiba's future in doubt
World shares were mixed on Tuesday after U.S. stock indexes inched to more records at the start of a week of profit updates from big U.S. companies. Germany's DAX lost 0.9% to 24,086.56 and the CAC 40 ...
Agilysys Posts Downbeat Earnings, Joins NXP Semiconductors And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Agilysys reported quarterly earnings of $33 cents per share which missed the analyst consensus estimate of 36 cents per share. The company reported quarterly sales of $76.70 million which beat the ...